한글목차

유전성 망막 질환의 동향과 전망

세계 유전성 망막 질환 시장은 2024년부터 2030년까지 7.5%의 연평균 복합 성장률(CAGR)로 성장을 지속하여 2030년까지 약 55억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 정부의 IRD 연구 및 새로운 치료법 개발에 대한 자금 지원 증가, IRD의 유병률 증가, IRD에 대한 사람들의 인식 증가입니다. 세계 유전성 망막 질환(IRD) 시장의 미래는 병원, 전문 클리닉, 외래수술센터(ASC), 재택치료 시장에서의 사업 기회로 인해 유망합니다.

유전성 망막 질환 시장 인사이트

Lucintel은 유전성 망막 질환의 조기 진단에 대한 수요 증가로 인해 진단 분야가 예측 기간 동안 높은 성장세를 보일 것으로 전망하고 있습니다.

이 시장에서 병원은 유전성 망막 질환 환자에게 진단, 치료, 재활을 포함한 다양한 서비스를 제공할 수 있는 자원과 전문 지식이 존재하기 때문에 이 시장에서 가장 큰 부문으로 남을 것입니다.

북미는 헬스케어 인프라가 잘 갖추어져 있어 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다.

• Q.1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q.2. 어떤 부문이 더 빠른 속도로 성장할 것이며, 그 이유는 무엇인가?
• Q.3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는 무엇인가?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은 무엇인가?
• Q.6. 이 시장의 새로운 트렌드와 그 이유는?
• Q.7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q.8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q.9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q.10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 유전성 망막 질환 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향 및 예측 분석(2018-2030년)

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 유전성 망막 질환 시장 동향(2018-2023년)과 예측(2024-2030년)
• 유형별 세계의 유전성 망막 질환 시장
  • 진단
  • 치료
• 질환 유형별 세계의 유전성 망막 질환 시장
  • 망막색소변성증
  • 스타가르트병
  • 색소 침착증
  • 원추세포 이상증
  • 맥락막 혈증
  • 레베르 선천성 흑암시
  • 황반 부종
  • 기타
• 최종 용도별 세계의 유전성 망막 질환 시장
  • 병원
  • 전문 클리닉
  • 외래수술센터(ASC)
  • 재택 헬스케어
  • 기타
• 유통 채널별 세계의 유전성 망막 질환 시장
  • 소매 판매
  • 직접 입찰

제4장 지역별 시장 동향 및 예측 분석(2018-2030년)

• 지역별 세계의 유전성 망막 질환 시장
• 북미의 유전성 망막 질환 시장
• 유럽의 유전성 망막 질환 시장
• 아시아태평양의 유전성 망막 질환 시장
• 기타 지역의 유전성 망막 질환 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 유형별 세계의 유전성 망막 질환 시장 성장 기회
  • 질환 유형별 세계의 유전성 망막 질환 시장 성장 기회
  • 최종 용도별 세계의 유전성 망막 질환 시장 성장 기회
  • 유통 채널별 세계의 유전성 망막 질환 시장 성장 기회
  • 지역별 세계의 유전성 망막 질환 시장 성장 기회
• 세계 유전성 망막 질환 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 유전성 망막 질환 시장 능력 확대
  • 세계의 유전성 망막 질환 시장의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 유력 기업의 기업 개요

• Spark Therapeutics
• Novartis
• Okuvision
• Nidek
• Invitae Corporation
• Zeiss
• Optos

영문목차

Inherited Retinal Disease Trends and Forecast

The future of the global inherited retinal disease (IRD) market looks promising with opportunities in the hospital, specialty clinic, ambulatory surgical center, and home healthcare markets. The global inherited retinal disease market is expected to reach an estimated $5.5 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are government's increasing funding for research into IRDs and the development of new treatments, rising prevalence of IRDs, and growing awareness of IRD among people.

A more than 150-page report is developed to help in your business decisions.

Inherited Retinal Disease by Segment

The study includes a forecast for the global inherited retinal disease by type, disease type, end use, distribution channel, and region.

Inherited Retinal Disease Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Diagnosis
• Therapy

Inherited Retinal Disease Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

• Retinitis Pigmentosa
• Stargardt'S Disease
• Achromatopsia
• Cone-Rod Dystrophy
• Choroideremia
• Leber Congenital Amaurosis
• Macular Edema
• Others

Inherited Retinal Disease Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Home Healthcare
• Others

Inherited Retinal Disease Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Retail Sales
• Direct Tender

Inherited Retinal Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Inherited Retinal Disease Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies inherited retinal disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the inherited retinal disease companies profiled in this report include-

• Spark Therapeutics
• Novartis
• Okuvision
• Nidek
• Invitae Corporation
• Zeiss
• Optos

Inherited Retinal Disease Market Insights

Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing demand for early diagnosis of inherited retinal diseases.

Within this market, hospital will remain the largest segment due to the presence of resources and expertise to provide a wide range of services for patients with inherited retinal diseases, including diagnosis, treatment, and rehabilitation.

North America is expected to witness highest growth over the forecast period due to well-developed healthcare infrastructure in the region.

Features of the Global Inherited Retinal Disease Market

Market Size Estimates: Inherited retinal disease market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Inherited retinal disease market size by various segments, such as by type, disease type, end use, distribution channel, and region in terms of ($B).

Regional Analysis: Inherited retinal disease market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, disease types, end uses, distribution channels, and regions for the inherited retinal disease market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the inherited retinal disease market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the inherited retinal disease market size?

Answer: The global inherited retinal disease market is expected to reach an estimated $5.5 billion by 2030.

Q.2 What is the growth forecast for inherited retinal disease market?

Answer: The global inherited retinal disease market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the inherited retinal disease market?

Answer: The major drivers for this market are government's increasing funding for research into IRDs and the development of new treatments, rising prevalence of IRDs, and growing awareness of IRD among people.

Q4. What are the major segments for inherited retinal disease market?

Answer: The future of the inherited retinal disease market looks promising with opportunities in the hospital, specialty clinic, ambulatory surgical center, and home healthcare markets.

Q5. Who are the key inherited retinal disease market companies?

Answer: Some of the key inherited retinal disease companies are as follows:

• Spark Therapeutics
• Novartis
• Okuvision
• Nidek
• Invitae Corporation
• Zeiss
• Optos

Q6. Which inherited retinal disease market segment will be the largest in future?

Answer: Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing demand for early diagnosis of inherited retinal diseases.

Q7. In inherited retinal disease market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to well-developed healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the inherited retinal disease market by type (diagnosis and therapy), disease type (retinitis pigmentosa, stargardt's disease, achromatopsia, cone-rod dystrophy, choroideremia, leber congenital amaurosis, macular edema, and others), end use (hospitals, specialty clinics, ambulatory surgical centers, home healthcare, and others), distribution channel (retail sales and direct tender), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Inherited Retinal Disease Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Inherited Retinal Disease Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Inherited Retinal Disease Market by Type
  • 3.3.1: Diagnosis
  • 3.3.2: Therapy
• 3.4: Global Inherited Retinal Disease Market by Disease Type
  • 3.4.1: Retinitis Pigmentosa
  • 3.4.2: Stargardt's Disease
  • 3.4.3: Achromatopsia
  • 3.4.4: Cone-Rod Dystrophy
  • 3.4.5: Choroideremia
  • 3.4.6: Leber Congenital Amaurosis
  • 3.4.7: Macular Edema
  • 3.4.8: Others
• 3.5: Global Inherited Retinal Disease Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Specialty Clinics
  • 3.5.3: Ambulatory Surgical Centers
  • 3.5.4: Home Healthcare
  • 3.5.5: Others
• 3.6: Global Inherited Retinal Disease Market by Distribution Channel
  • 3.6.1: Retail Sales
  • 3.6.2: Direct Tender

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Inherited Retinal Disease Market by Region
• 4.2: North American Inherited Retinal Disease Market
  • 4.2.2: North American Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
• 4.3: European Inherited Retinal Disease Market
  • 4.3.1: European Inherited Retinal Disease Market by Type: Diagnosis and Therapy
  • 4.3.2: European Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
• 4.4: APAC Inherited Retinal Disease Market
  • 4.4.1: APAC Inherited Retinal Disease Market by Type: Diagnosis and Therapy
  • 4.4.2: APAC Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
• 4.5: ROW Inherited Retinal Disease Market
  • 4.5.1: ROW Inherited Retinal Disease Market by Type: Diagnosis and Therapy
  • 4.5.2: ROW Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Inherited Retinal Disease Market by Type
  • 6.1.2: Growth Opportunities for the Global Inherited Retinal Disease Market by Disease Type
  • 6.1.3: Growth Opportunities for the Global Inherited Retinal Disease Market by End Use
  • 6.1.4: Growth Opportunities for the Global Inherited Retinal Disease Market by Distribution Channel
  • 6.1.5: Growth Opportunities for the Global Inherited Retinal Disease Market by Region
• 6.2: Emerging Trends in the Global Inherited Retinal Disease Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Inherited Retinal Disease Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Inherited Retinal Disease Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Spark Therapeutics
• 7.2: Novartis
• 7.3: Okuvision
• 7.4: Nidek
• 7.5: Invitae Corporation
• 7.6: Zeiss
• 7.7: Optos